HIGHLIGHTS
- who: Regulatory and collaborators from the (UNIVERSITY) have published the research work: RESEARCH Open Access, in the Journal: (JOURNAL)
- what: Regardless of external regulation, our 3D printing team strives to provide high-quality additive manufacturing support to our healthcare community.
SUMMARY
With the U.S. Food and Drug Administration (FDA) releasing a discussion paper on regulation of 3D printing in 2021, it is only a matter of time until formal regulation is placed on 3D printing programs. Within the QMS, the FDA requires the use of a document control system (DCS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.